231 related articles for article (PubMed ID: 30307748)
41. Escherichia coli Shiga toxin.
Nakao H; Takeda T
J Nat Toxins; 2000 Aug; 9(3):299-313. PubMed ID: 10994531
[TBL] [Abstract][Full Text] [Related]
42. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins.
Lopez EL; Diaz M; Grinstein S; Devoto S; Mendilaharzu F; Murray BE; Ashkenazi S; Rubeglio E; Woloj M; Vasquez M
J Infect Dis; 1989 Sep; 160(3):469-75. PubMed ID: 2668430
[TBL] [Abstract][Full Text] [Related]
43. Treatment of typical (enteropathic) hemolytic uremic syndrome.
Bitzan M; Schaefer F; Reymond D
Semin Thromb Hemost; 2010 Sep; 36(6):594-610. PubMed ID: 20865636
[TBL] [Abstract][Full Text] [Related]
44. An Unusual Case of Clostridium Difficile Colitis and Hemolytic Uremic Syndrome in a Teenager.
Dasgupta K; Santos A; McCaul K
S D Med; 2019 Jul; 72(7):294-297. PubMed ID: 31461583
[TBL] [Abstract][Full Text] [Related]
45. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli 0111.
Azadi R; Calabrese K; Stroup J
J Am Osteopath Assoc; 2010 Sep; 110(9):538-44. PubMed ID: 20876839
[TBL] [Abstract][Full Text] [Related]
46. Genetic Susceptibility to Postdiarrheal Hemolytic-Uremic Syndrome After Shiga Toxin-Producing Escherichia coli Infection: A Centers for Disease Control and Prevention FoodNet Study.
Kallianpur AR; Bradford Y; Mody RK; Garman KN; Comstock N; Lathrop SL; Lyons C; Saupe A; Wymore K; Canter JA; Olson LM; Palmer A; Jones TF
J Infect Dis; 2018 Mar; 217(6):1000-1010. PubMed ID: 29216383
[TBL] [Abstract][Full Text] [Related]
47. [Therapy for children with Shiga toxin-E. coli-associated hemolytic uremic syndrome].
Ito K; Hattori M; Matsumoto N
Nihon Rinsho; 2002 Jun; 60(6):1126-30. PubMed ID: 12078084
[TBL] [Abstract][Full Text] [Related]
48. Heme as Possible Contributing Factor in the Evolvement of Shiga-Toxin
Wijnsma KL; Veissi ST; de Wijs S; van der Velden T; Volokhina EB; Wagener FADTG; van de Kar NCAJ; van den Heuvel LP
Front Immunol; 2020; 11():547406. PubMed ID: 33414780
[TBL] [Abstract][Full Text] [Related]
49. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006.
Espié E; Grimont F; Mariani-Kurkdjian P; Bouvet P; Haeghebaert S; Filliol I; Loirat C; Decludt B; Minh NN; Vaillant V; de Valk H
Pediatr Infect Dis J; 2008 Jul; 27(7):595-601. PubMed ID: 18520972
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome.
Hostetter SJ; Helgerson AF; Paton JC; Paton AW; Cornick NA
BMC Res Notes; 2014 Jun; 7():331. PubMed ID: 24890228
[TBL] [Abstract][Full Text] [Related]
51. Ockham's razor defeated: about two atypical cases of hemolytic uremic syndrome.
Schwarz C; Brehon A; Mousseaux C; Luque Y; Senet P; Mariani P; Mohamadou I; Zafrani L; Frémeaux-Bacchi V; Rondeau E; Buob D; Rafat C
BMC Nephrol; 2020 Jul; 21(1):269. PubMed ID: 32652955
[TBL] [Abstract][Full Text] [Related]
52. [Role of the Shiga toxin in the hemolytic uremic syndrome].
Creydt VP; Nuñez P; Boccoli J; Silberstein C; Zotta E; Goldstein J; Ibarra C
Medicina (B Aires); 2006; 66 Suppl 3():11-5. PubMed ID: 17354471
[TBL] [Abstract][Full Text] [Related]
53. Seizure as First Manifestation of Hemolytic Uremic Syndrome with Bacteremia due to Shiga Toxin-Producing Escherichia coli.
Schwartz L; Riese J
R I Med J (2013); 2024 Apr; 107(4):7-9. PubMed ID: 38536130
[TBL] [Abstract][Full Text] [Related]
54. New Therapeutic Developments against Shiga Toxin-Producing Escherichia coli.
Melton-Celsa AR; O'Brien AD
Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104346
[TBL] [Abstract][Full Text] [Related]
55. Shiga toxin-producing Escherichia coli O171:H25 strain isolated from a patient with haemolytic uraemic syndrome.
Lepšanović Z; Opačić D; Lazić S; Herpay M; Tóth S; Kostić M; Kucsera I
Acta Microbiol Immunol Hung; 2012 Jun; 59(2):215-24. PubMed ID: 22750781
[TBL] [Abstract][Full Text] [Related]
56. Microparticle generation and leucocyte death in Shiga toxin-mediated HUS.
Ge S; Hertel B; Emden SH; Beneke J; Menne J; Haller H; von Vietinghoff S
Nephrol Dial Transplant; 2012 Jul; 27(7):2768-75. PubMed ID: 22234918
[TBL] [Abstract][Full Text] [Related]
57. Atypical hemolytic uremic syndrome: a clinical conundrum.
Bajracharya P; Jain A; Baracco R; Mattoo TK; Kapur G
Pediatr Nephrol; 2016 Oct; 31(10):1615-24. PubMed ID: 27139899
[TBL] [Abstract][Full Text] [Related]
58. Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease.
Walker CL; Applegate JA; Black RE
J Health Popul Nutr; 2012 Sep; 30(3):257-61. PubMed ID: 23082627
[TBL] [Abstract][Full Text] [Related]
59. Shiga toxin associated hemolytic uremic syndrome.
Keir LS
Hematol Oncol Clin North Am; 2015 Jun; 29(3):525-39. PubMed ID: 26043390
[TBL] [Abstract][Full Text] [Related]
60. Hemolytic Uremic Syndrome: A Contemporary Pediatric Experience.
Alfandary H; Rinat C; Gurevich E; Eisenstein I; Goldberg O; Kropach N; Landau D
Nephron; 2020; 144(3):109-117. PubMed ID: 31935726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
